Quick Answer
Vir Biotechnology, Inc. reported Net Income of -$437.99 million for fiscal year 2025.
Vir Biotechnology, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$437.99M | +16.1% |
| 2024 | -$521.96M | +15.1% |
| 2023 | -$615.06M | -219.2% |
| 2022 | $515.84M | -2.4% |
| 2021 | $528.58M | +277.0% |
| 2020 | -$298.67M | -71.0% |
| 2019 | -$174.68M | -50.7% |
| 2018 | -$115.88M | -65.9% |
| 2017 | -$69.85M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$163.14M | +23.7% | -47.0% |
| June 30, 2025 | -$110.96M | +19.8% | +8.3% |
| March 31, 2025 | -$120.97M | -85.3% | +43.4% |
| September 30, 2024 | -$213.72M | -30.8% | -54.4% |
| June 30, 2024 | -$138.38M | +29.0% | -112.0% |
| March 31, 2024 | -$65.28M | +53.7% | +60.1% |
| September 30, 2023 | -$163.41M | -193.2% | +16.1% |
| June 30, 2023 | -$194.78M | -154.6% | -38.2% |
- Vir Biotechnology, Inc. showed an increase of +16.1% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Vir Biotechnology, Inc.’s net income has declined by 527.0% (from -$69.85 million to -$437.99 million).
- The most recent figure is from Vir Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: